News -

Join us for our CiPA meeting at SPS in Prague on 29th September

We are pleased to invite you to a meeting about CiPA, its impact and how it can change the way we do drug development in the future.

Tuesday, 29th September, 2015
12:30 PM - 13:30 PM meeting

Light lunch will be served

Venue:

Meeting room Club E
Prague Congress Centre
5. kvetna 65, 140 21 Prague 4,
Czech Republic

For this meeting we have the following speakers:

  • Bernard Fermini, co-chair of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) Ion Channel Working Group, member of the CiPA Steering Committee.
    CiPA: The four letter word that may revolutionize in vitro cardiac safety testing
  • Simon Hebeisen, BSYS
    Evolving market needs in safety screening: beyond hERG and CiPA

  • Marc Rogers, Metrion Bioscience
    Using high quality HTS automated patch clamp data from human cardiac ion channels and in silico action potential modelling to cost–effectively predict QT prolongation and arrhythmia risk for CiPA

Make sure to register for this meeting.

We look forward to seeing you in Prague.

Topics

  • Health, Health Care, Pharmaceuticals

Categories

  • cipa
  • qpatch
  • herg
  • safety screening
  • patch clamp
  • hts
  • ion channels

Contacts

Mattias Bengtsson

Press contact CEO, Biolin Scientific +46 709577337